Drug Shortage Report for APO-GABAPENTIN
Report ID | 142976 |
Drug Identification Number | 02244304 |
Brand name | APO-GABAPENTIN |
Common or Proper name | GABAPENTIN |
Company Name | APOTEX INC |
Market Status | MARKETED |
Active Ingredient(s) | GABAPENTIN |
Strength(s) | 100MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL ORAL |
Packaging size | 100 BTL and 500 BTL |
ATC code | N03AX |
ATC description | ANTIEPILEPTICS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2021-07-19 |
Estimated end date | 2021-10-29 |
Actual end date | 2021-10-27 |
Shortage status | Resolved |
Updated date | 2021-10-28 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 150 SIGNET DRIVE TORONTO, ONTARIO CANADA M9L 1T9 |
Company contact information | Apotex Customer Service - 1-877-427-6839 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v14 | 2021-10-28 | French | Compare |
v13 | 2021-10-28 | English | Compare |
v12 | 2021-10-15 | French | Compare |
v11 | 2021-10-15 | English | Compare |
v10 | 2021-10-07 | French | Compare |
v9 | 2021-10-07 | English | Compare |
v8 | 2021-09-07 | French | Compare |
v7 | 2021-09-07 | English | Compare |
v6 | 2021-08-13 | French | Compare |
v5 | 2021-08-13 | English | Compare |
v4 | 2021-08-13 | French | Compare |
v3 | 2021-08-13 | English | Compare |
v2 | 2021-07-23 | French | Compare |
v1 | 2021-07-23 | English | Compare |
Showing 1 to 14 of 14